Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Regulatory News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PDMR Dealings

7 Jan 2020 12:09

RNS Number : 0232Z
Amryt Pharma PLC
07 January 2020
 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Joe Wiley

 

 

 

 

2

Reason for the notification

 

a)

Position/status

CEO

 

 

 

 

 

 

b)

Initial Notification Amendment

Initial Notification

 

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Amryt Pharma plc

 

b)

LEI

213800YNUJEOJ8L4T95

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument,

type of

instrument

Identification code

Ordinary shares of £0.06 each

 

GB00BKLTQ412

 

b)

Nature of the transaction

Purchase of Shares

 

 

 

 

 

 

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£1.219

7,999 shares

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

7,999 shares

 

£9,750.78

 

 

 

 

 

e)

Date of the transaction

January 7th, 2020

 

 

 

f)

Place of the transaction

London Stock Exchange, AIM

 

 

 

 

 

 

g)

Additional Information

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBRMTTMTMMBAM
Date   Source Headline
24th Apr 20177:00 amRNSFirst Patient Enrolled
10th Apr 20175:21 pmRNSDirector/PDMR Shareholding
6th Apr 20174:13 pmRNSPosting of Annual Report 2016 and Notice of AGM
30th Mar 20177:00 amRNSFinal Results
28th Mar 20177:00 amRNSPhase 3 Clinical Trial for AP101 commenced
27th Mar 20177:00 amRNSSenior Management Appointment
8th Mar 20177:00 amRNSNotice of Results
6th Mar 20177:00 amRNSAP101 trial discussions completed with FDA & EMA
9th Feb 20177:00 amRNSDirectorate Change
7th Feb 20177:00 amRNSGrant of patent in Japan for AP101 (Episalvan)
6th Feb 20177:00 amRNSPre-clinical study results
5th Dec 20167:00 amRNSTransformational Licence Agreement
2nd Dec 20167:00 amRNSEUR20m Facility with European Investment Bank
7th Nov 20167:00 amRNSOrphan drug designation for Acromegaly Compound
19th Sep 20167:00 amRNSAppointment of Chief Medical Officer
13th Sep 20167:00 amRNSHalf-year Report
13th Sep 20167:00 amRNSGrant of US patent for lead drug, Episalvan
7th Jul 201612:54 pmRNSResult of AGM
27th Jun 20167:00 amRNSMarkus Ziener appointed as Non-Executive Director
9th Jun 20167:00 amRNSFinancial Results
2nd Jun 20164:34 pmRNSNotice of Results
21st Apr 20164:35 pmRNSHolding(s) in Company
19th Apr 20167:00 amRNSAdmission to trading on AIM and ESM
18th Apr 20162:30 pmRNSESM Schedule 1 Update
18th Apr 20162:30 pmRNSSchedule One update - Fastnet Equity plc
18th Apr 201612:41 pmRNSResult of General Meeting and Change of Name
31st Mar 20167:35 amRNSESM Schedule 1
31st Mar 20167:30 amRNSSchedule One - Fastnet Equity plc
31st Mar 20167:30 amRNSRestoration - Fastnet Equity plc
31st Mar 20167:00 amRNSProposed Acquisition of Amryt Pharmaceuticals
22nd Feb 20167:30 amRNSPotential Acquisition and Statement re Suspension
22nd Feb 20167:30 amRNSSuspension - Fastnet Equity plc
21st Dec 20157:01 amRNSAppointment of Non-executive Director
21st Dec 20157:00 amRNSInterim Results
18th Dec 20157:00 amRNSDemerger of Oil and Gas Assets
30th Sep 20153:12 pmRNSResult of Annual General Meeting
4th Sep 20157:00 amRNSFinal Results
28th Aug 20153:31 pmRNSResult of General Meeting
11th Aug 20153:35 pmRNSProposed adoption of Investing Policy/Notice of GM
3rd Jul 20153:22 pmRNSDirector/PDMR Shareholding
26th Jun 20152:45 pmRNSDirector/PDMR Shareholding
2nd Jun 20152:27 pmRNSHolding(s) in Company
1st Jun 20157:00 amRNSCorporate Update
26th Mar 20157:00 amRNSCeltic Sea Portfolio
27th Jan 201512:56 pmRNSDirectorate Change
9th Jan 201512:49 pmRNSHolding(s) in Company
2nd Jan 20157:00 amRNSExpiry of Tendrara Option Agreement
19th Dec 20147:00 amRNSInterim Results
10th Dec 20147:00 amRNSBoard changes & operational update
1st Dec 20143:00 pmRNSResponse to press speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.